0.9 C
New York
Tuesday, December 18, 2018
- Advertisement -

Featured Authors

Editor's Pick

Indivior to launch cheaper opioid addiction drug; maintains forecast

British drugmaker Indivior Plc said on Tuesday it would launch a cheaper version of its blockbuster opioid addiction treatment drug, while maintaining its full-year profit and revenue forecast.

China first to approve AstraZeneca, FibroGen anaemia drug

China has become the first country to approve a new anaemia drug from AstraZeneca and FibroGen, well before decisions by regulators in the United States or Europe.

Financial News

Events

Research and Dev

New Podcast

Trends in The New Value-Based Reimbursement Model

177FollowersFollow
2,446FollowersFollow

Appointments